A detailed history of Engineers Gate Manager LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 18,501 shares of INVA stock, worth $330,057. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,501
Holding current value
$330,057
% of portfolio
0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.33 - $20.04 $302,121 - $370,760
18,501 New
18,501 $357,000
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $85,934 - $96,493
-6,947 Reduced 24.59%
21,303 $276,000
Q2 2023

Aug 14, 2023

BUY
$11.39 - $13.72 $321,767 - $387,590
28,250 New
28,250 $359,000
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $423,811 - $555,590
36,504 New
36,504 $424,000
Q4 2020

Feb 16, 2021

SELL
$9.33 - $12.48 $200,380 - $268,032
-21,477 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$10.33 - $14.49 $221,857 - $311,201
21,477 New
21,477 $224,000
Q1 2020

May 15, 2020

SELL
$8.11 - $15.23 $90,994 - $170,880
-11,220 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$10.28 - $14.38 $637,740 - $892,092
-62,037 Reduced 84.68%
11,220 $159,000
Q3 2019

Nov 14, 2019

BUY
$10.05 - $14.55 $331,047 - $479,277
32,940 Added 81.7%
73,257 $772,000
Q2 2019

Aug 14, 2019

BUY
$13.1 - $14.95 $528,152 - $602,739
40,317 New
40,317 $587,000
Q1 2019

May 15, 2019

SELL
$13.69 - $20.06 $1.66 Million - $2.43 Million
-121,095 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$13.96 - $18.26 $1.69 Million - $2.21 Million
121,095 New
121,095 $2.11 Million
Q2 2018

Aug 03, 2018

SELL
$13.44 - $17.59 $1.27 Million - $1.66 Million
-94,477 Closed
0 $0
Q1 2018

May 07, 2018

BUY
$13.8 - $16.99 $1.3 Million - $1.61 Million
94,477 New
94,477 $1.58 Million
Q4 2017

Feb 01, 2018

SELL
$11.73 - $14.75 $1.24 Million - $1.56 Million
-105,687 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$12.06 - $14.12 $1.27 Million - $1.49 Million
105,687
105,687 $1.49 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.